Patients receiving a new mRNA vaccine for skin cancer are 49% less likely to experience recurrence or death three years after treatment. Research published in SciImmunology is investigating a new form of immunotherapy for cancers that are resistant to conventional T cell therapies. This includes the potential use of dendritic cells in an allogeneic manner, as discussed by SeventureP, and a cancer test developed at Brigham and Women's Hospital that could broaden the application of immunotherapy. The nanoparticle HIV vaccine candidate eOD-GT8 60mer, studied by Fred Hutchinson Cancer Research Center and the International AIDS Vaccine Initiative (IAVI), has generated strong T cell and memory B cell responses in a phase 1 trial. Furthermore, a chikungunya vaccine based on virus-like particles has shown promising results in a phase 2 trial conducted by researchers from the Diamond Lab and Washington University School of Medicine in Pathology. Nanoparticles designed to carry medicine have shown effectiveness in reducing symptoms of inflammatory bowel disease in mice, according to Science Advances. However, there are alarming reports from sources like MakisMD, claiming that Pfizer and Moderna's COVID-19 mRNA vaccines are causing 'Turbo Cancers', including aggressive ovarian cancers, and a separate report of a 65-year-old man developing a tumor after receiving the COVID vaccine.
REPORT: COVID Vax Caused Tumor in 65-Year-Old. Read more: https://t.co/lmCRKT0Nh7 A 65-year-old man developed a tumor on his left shoulder three months after receiving the COVID-1...
COVID vaccine causes man to get tumor https://t.co/JpEpIlZc0J
Medicine-carrying nanoparticles have been shown to improve physical and psychological symptoms in mice with inflammatory bowel disease. Learn more in @ScienceAdvances: https://t.co/RxlpdZ25h3 https://t.co/nAxy8Pdupk
A vaccine for #chikungunya based on virus-like particles induces strong responses in humans and generates neutralizing antibodies that protect mice against multiple #alphaviruses, showed a study from May of a phase 2 trial. @msdiamondlab @wusm_pathology https://t.co/yeFGByw3rg https://t.co/VmQ3GB5qDv
NEW ARTICLE: TURBO CANCER - OVARIAN Cancers in COVID-19 mRNA Vaccinated: rapid growth, huge tumors, aggressive, not responsive to chemo, poor prognosis - 26 Tragic Cases Pfizer & Moderna COVID-19 mRNA Vaccines are causing Turbo Cancers. Ovarian Turbo Cancers are REAL &… https://t.co/m8pc4pwj9q
New form of immunotherapy under investigation for cancer that resists conventional T cell therapies https://t.co/HPUoz7G9kH https://t.co/LpT3A7PQkb
#Cancer test shows promise for bringing the benefits of immunotherapy to more #patients @BrighamWomens https://t.co/3Rt5jJJyjQ https://t.co/NCcfsKshIC
Vaccines for cancer! https://t.co/Gz5jHOswPg
Wow - vaccines for cancer! https://t.co/5RrVwrYlel
Exciting how dendritic cells may be used in an allogeneic manner...to fight cancer $NWBO $TSOI https://t.co/RBIZKtWOoW
The nanoparticle #HIV vaccine candidate eOD-GT8 60mer generates robust vaccine-specific responses from T cells and memory B cell expansion in humans, showed an analysis of a first-in-human phase 1 trial published in May. @fredhutch @IAVI https://t.co/oTaUuGKHAf https://t.co/kpeHA40kIR
New form of immunotherapy under investigation for #cancer that resists conventional T cell therapies @SciImmunology https://t.co/Zi01jWvKbQ https://t.co/QyfAlDoQ49
Good news of the day: Patients receiving a new mRNA vaccine for skin cancer are “49% less likely to experience recurrence or death a median of three years after treatment.” https://t.co/KkUohkLkbr